Use CaseR and DPharma & Biotech / Pharma & Biotech

Model out hypothesis of drug impact

Once a drug target has been identified, the drug compound itself must be evaluated for safe use in living organisms before live testing can begin. This includes researching how the drug will be metabolised by the body and identifying potential toxic interactions and side effects.

🛡

Risk reduction

Risk reduction - Predictive diagnosis

Cost

Cost - Targeted Trials/ Precision testing

Cost

Cost - Optimise resource allocation

Linked Case Studies

Case Study

GlaxoSmithKline

GlaxoSmithKline (GSK) plans to reduce drug discovery to trial time from six years to 12 months using machine learning models to predict molecular behaviour

→

←Back to Use Case Library

Editor: sdg